
Hansen Medical
Founded Year
2002Stage
Acquired | AcquiredTotal Raised
$57.8MValuation
$0000About Hansen Medical
Hansen Medical makes an electromechanical robotic system which provides accurate and efficient control over catheter movement during interventional procedures. The system is controlled by the physician from a workstation that integrates visualization, guidance, and patient physiologic data. (NASDAQ: HNSN).
Missing: Hansen Medical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Hansen Medical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Hansen Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Hansen Medical is included in 4 Expert Collections, including Robotics.
Robotics
1,974 items
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
Digital Health
10,338 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Medical Devices
3,088 items
Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)
Clinical Encounter Tech
625 items
Hansen Medical Patents
Hansen Medical has filed 174 patents.
The 3 most popular patent topics include:
- Cardiac electrophysiology
- Catheters
- Electrophysiology

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
3/22/2017 | 11/22/2022 | Medical equipment, Surgical instruments, Medical technology, Catheters, Medical testing equipment | Grant |
Application Date | 3/22/2017 |
---|---|
Grant Date | 11/22/2022 |
Title | |
Related Topics | Medical equipment, Surgical instruments, Medical technology, Catheters, Medical testing equipment |
Status | Grant |
Latest Hansen Medical News
Mar 13, 2023
Search jobs 13-Mar-2023 Robotic Catheterization Systems Market is set to experience a significant growth of 14.8% CAGR from 2022 to 2029 [193 Pages Report] A recent clinical study radiation level research with robotic catheterization and normal cardiac intervention procedures reveals that robotic catheterization systems show reduction of ionizing radiation exposure by 95%. This factor will be prominent in pushing the preference for robotic catheterization systems as an effective procedure for catheterization. Projected to reach US$ 42.9 Mn by the end of 2022, robotic catheterization systems market is set to thrive at an impressive CAGR of 14.8% during the forecast period (2022 – 2029). Interventional and surgical robotic systems have already made a significant impact on how surgeries are performed and are being increasingly adopted in modern operating rooms. Robotic catheterization systems have proved their abilities to perform interventional procedures with immensely low operator radiation exposure in comparison to the tradition catheterization procedures. Procedures where clinicians are given navigational and mechanical tools that permit definite actions or part of the procedure to be executed autonomously with a level of precession and control are possible only with robot-assisted catheterization. Get a Sample of this Research Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-9667 Key Takeaways – Robotic Catheterization Systems Market Study Popularity of robotic catheterization systems, increasing system awareness, improving reimbursement scenarios for percutaneous coronary intervention (PCI), larger patient pool for coronary artery diseases are key factors influencing the robotic catheterization systems market in developed countries. High upfront cost is posing a negative impact on end users’ decision to purchase robotic catheterized systems. To rework this problem, Hansen Medical is offering sensei system at a competitive pricing depicting lower accessory cost and lower total cost per procedure. Robotic catheterization systems installed in Chesapeake Regional Healthcare marks as the first fully integrated catheterization laboratory installed in its all intervention operating room. In terms of product type, electromechanical robotic catheterization systems with comparatively higher technical advantage over magnetic-guided robotic catheterization systems is expected to generate significant revenue. In terms of application, increasing adoption of robotic catheterization for percutaneous coronary intervention as compared to cardiac electrophysiology procedure marks higher revenue potential. The first ever successful robotic PCI procedure in Asia Pacific that delivered positive results will be offering an inception point for the growth of robotic catheterization systems market in developing Asian economies. Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9667 Report Scope Market Leaders on Acquisition Spree In reference to the trend in other medical device markets, key factors impacting the robotic catheterization systems market are partnerships and mergers observed in recent years. Key manufacturers are entering the robotic catheterization systems market by strategically expanding their reach through acquisitions and mergers, considering the increasing demand for these systems. Product bundling of robotic catheterization and accessory systems at promotional rates and research contracts are forcing a decline in ASPs. Companies are focusing on limiting operational expenses to grow profitability. In contrast to these market changes, another significant factor influencing the robotic catheterization systems market is the exit and entrance of co-participating companies. In August 2022, Corindus Vascular Robotics Inc., a prominent developer of precision vascular robotics, declared that it has settled on acquisition by Siemens Healthineers AG., representing a collective purchase price of approximately $1.1 billion. In April 2016, Hansen Medical Inc. was acquired by Auris Surgical Robotics Inc. in an arrangement with roughly US$ 80 Mn of equity value. With Hansen portfolio, Auris attained Magellan Robotic System, employed in navigating peripheral blood vessels in endovascular procedures, and Sensei Robotic System, a robotically steerable catheter system. Looking for More Insights? Robotic catheterization systems market, a new study from Future Market Insights, provides unparalleled insights on evolution of the robotic catheterization systems market during 2014 – 2021 and presents demand projections during 2022 – 2029 on the basis of product category (Electromechanical robotic catheterization systems, magnetic-guided robotic catheterization systems), application (percutaneous coronary intervention, cardiac electrophysiology procedures), and end user (hospitals, ambulatory surgical centers, catheterization laboratories) across seven prominent regions. About Future Market Insights (FMI) Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact:
Hansen Medical Frequently Asked Questions (FAQ)
When was Hansen Medical founded?
Hansen Medical was founded in 2002.
Where is Hansen Medical's headquarters?
Hansen Medical's headquarters is located at 800 East Middlefield Road, Mountain View.
What is Hansen Medical's latest funding round?
Hansen Medical's latest funding round is Acquired.
How much did Hansen Medical raise?
Hansen Medical raised a total of $57.8M.
Who are the investors of Hansen Medical?
Investors of Hansen Medical include Auris Health, Prospect Venture Partners, Skyline Ventures, Kearny Venture Partners, Thomas Weisel Partners and 6 more.
Who are Hansen Medical's competitors?
Competitors of Hansen Medical include CMR Surgical, Activ Surgical, Vicarious Surgical, Quantum Surgical, Medrobotics and 9 more.
Compare Hansen Medical to Competitors
Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support. The company was formerly known as Cardiorobotics and Innvoention Technologies.

CMR Surgical operates as a surgical robotics company developing universal robotic systems for minimal access surgery. It aims to make minimal-access surgery universally accessible and affordable by expanding the range of procedures that can be performed robotically. CMR Surgical was formerly known as Cambridge Medical Robotics. It was founded in 2014 and is based in Cambridge, United Kingdom.

Quantum Surgical is a surgical robotics start-up building next-generation smart tools for minimally invasive therapies, beginning with interventional oncology. The robotic platform will enable physicians to better assess, plan, and treat a broad spectrum of medical conditions. The Company is developing end-to-end solutions for interventional oncology.
Activ Surgical is a digital surgery company that focuses on enhanced real-time visualization capabilities for surgeons. The company develops and strengthens software combining advanced augmented reality (AR), artificial intelligence (AI), and machine learning (ML) technology. Its products include ActivSight, ActivEdge, ActivPerfusion, and ActivICG. The company was founded in 2017 and is based in Boston, Massachusetts.
Intuitive Surgical develops, manufactures and markets robotic surgical systems under the da Vinci Surgical brand.
Bionaut Labs is a biotech company that designs and manufactures intra- tissue navigation using Bionaut nano, microrobots operating inside the body. It develops tiny robots to deliver drugs into the brain, controlled by magnetic propulsion, to target hard-to-treat diseases. Its devices cater to therapeutic, microsurgical, diagnostic, sensing, monitoring, and stimulatory issues. The company was founded in 2016 and is based in Los Angeles, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.